VUNO Med-DeepBrain

by VUNO  · Based in South Korea → — View the Invisible, Know the Unknown
Geriatrics Neurology Radiology
Website
Claim this tool
Is this the maker? Claim the company →

Regulatory Status Disclosed

Overview

VUNO Med-DeepBrain is an AI-based medical device designed for the quantitative analysis of the brain from MRI scans. It aids in the diagnosis of neurodegenerative diseases, including Alzheimer’s disease and vascular dementia, by automatically segmenting the brain into over 100 regions. The software provides volumetric data, evaluates white matter hyperintensity and cortical thickness, and compares individual patient data to healthy populations to generate normative percentile scores. This information is presented in customizable reports, assisting healthcare professionals in early detection and management of conditions that cause brain volume change and atrophy. The software is designed to integrate seamlessly with existing workflows, including PACS, and can analyze MRI images within approximately one minute.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-based brain volumetric software
  • Extracts quantitative data from MRI scans
  • Brain parcellation into over 100 regions
  • Provides volumetric data on multiple brain regions
  • Evaluates white matter hyperintensity (WMH) and cortical thickness
  • Compares patient atrophy data to healthy populations
  • Provides normative percentile scores and volume information
  • Customizable reports with statistical analysis, graphs, and diagrams
  • Analyzes brain MRI images within 1 minute
  • Seamless integration with PACS (DICOM standard)

Use Cases

  • Diagnosis of Alzheimer's disease (AD)
  • Diagnosis of other neurodegenerative conditions
  • Early detection of dementia
  • Predicting amyloid positivity in subjective cognitive decline (SCD)
  • Assessing cerebral small vessel disease
  • Monitoring complications from anti-amyloid therapy (ARIA)

What Physicians Need to Know

Brain MRI Analysis
VUNO Med-DeepBrain is an AI-based software that performs quantitative analysis of brain MRI scans. It segments the brain into over 100 distinct regions, providing volumetric data, evaluating white matter hyperintensity (WMH), and cortical thickness.
Neurodegenerative Disease Screening
The tool aids in the diagnosis of neurodegenerative conditions such as Alzheimer's disease and other disorders causing brain volume change and atrophy. It compares individual patient atrophy data to healthy populations, offering normative percentile scores and volume information.
Analysis Speed
VUNO Med-DeepBrain can analyze a brain MRI image and provide parcellation results within 1 minute, aiming to reduce time to diagnosis.
Early Detection Potential
The software has demonstrated effectiveness in predicting amyloid positivity in individuals with subjective cognitive decline (SCD), suggesting its utility in the early detection of Alzheimer's disease.
Report Generation
It generates customizable reports that include statistical analysis results, visualized graphs, and diagrams, enhancing communication and patient understanding.
Regulatory Clearances
VUNO Med-DeepBrain has received FDA 510(k) clearance in the United States, CE Mark in Europe, and approval from MFDS (Korea).
Physician Tip

Leverage VUNO Med-DeepBrain's quantitative brain data, including volumetric measurements, cortical thickness, and white matter hyperintensity, for objective assessment of neurodegenerative changes. Utilize the normative percentile scores to compare patient data against healthy populations, aiding in the early identification and monitoring of conditions like Alzheimer's disease. The rapid 1-minute analysis speed can significantly streamline workflow, allowing for quicker diagnostic insights. Employ the customizable reports for clear communication with patients and for tracking disease progression over time.

VUNO Med-DeepBrain is designed for seamless integration with existing Picture Archiving and Communication Systems (PACS) through the DICOM standard format. It accepts 3D T1-weighted and 2D T2 FLAIR brain MR images as input. The system provides output in the form of comprehensive reports, including statistical analysis, visualized graphs, and diagrams, which can be easily incorporated into clinical documentation.

Details

Category Neurology AI, Radiology & Imaging AI
Pricing Unknown
Mobile App1
Compliance
BAA AvailableUnknown
HIPAA CompliantUnknown
FDA Status Cleared AI-estimated
Integrations
EHR Not specified
Specialties Geriatrics, Neurology, Radiology

What the Web Says

VUNO Med-DeepBrain is an AI-powered medical device that analyzes brain MRI images to aid in the diagnosis of neurodegenerative diseases like Alzheimer's and vascular dementia. It quantifies brain atrophy and detects cerebral small vessel disease, providing detailed reports to physicians. The device has received regulatory approvals in South Korea and the US, and studies have shown its effectiveness in early diagnosis and agreement with neuroradiologist assessments.

Overall: Positive

Strengths

  • Aids in early diagnosis of neurodegenerative diseases, including Alzheimer's and vascular dementia.
  • Automatically analyzes brain MRI images, segmenting the brain into over 100 distinct areas and quantifying atrophy.
  • Provides comprehensive, standardized reports that can help physicians make more accurate judgments.
  • Reduces the time spent on report generation while maintaining high diagnostic standards.
  • Demonstrated high agreement rates (84%) with board-certified neuroradiologists' assessments.
  • Received FDA clearance in the U.S. and national health insurance coverage in Korea, facilitating broader adoption.

Limitations

  • No specific cons were found in the provided search results from physicians, healthcare IT, or tech reviewers.
  • No reviews or opinions from Reddit, G2, or Capterra specifically for "VUNO Med-DeepBrain" were found; the search results for these platforms referred to different AI products or companies.

Based on reviews from: Korea Biomedical Review, Radiology Business, Practical Neurology, AI Health Index, PR Newswire, Thieme E-Journals - Indian Journal of Radiology and Imaging

Last updated: 2026-10-20

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate VUNO Med-DeepBrain

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

Practical Neurology
AI-Based Brain Volumetric Software, VUNO Med-DeepBrain, Receives FDA 510(k) Clearance
VUNO Med-DeepBrain, an AI-based software that extracts quantitative brain data from MRI scans, received FDA 510(k) clearance in October 2023. The software provides volumetric data on brain regions, evaluates white matter hyperintensity and cortical thickness, and has potential applications in diagnosing Alzheimer's and other neurodegenerative conditions.
2023-10
PR Newswire
VUNO Secures FDA 510(k) Clearance for VUNO Med®-DeepBrain®
VUNO Inc. announced in October 2023 that its AI-powered brain quantification device, VUNO Med®-DeepBrain®, received 510(k) clearance from the FDA. The software automates the process of identifying and quantifying brain structures from MRI images, providing valuable data for dementia and other neurodegenerative diseases.
2023-10
Radiology Business
AI brain imaging device receives FDA clearance
South Korean startup Vuno's AI-powered brain imaging device, Vuno Med-DeepBrain, received FDA 510(k) certification in October 2023, enabling its expansion into the U.S. market. The technology enhances MRI images, segments the brain into 100 distinct areas, and measures brain activity reduction to aid in the early diagnosis of dementia and neurodegenerative conditions.
2023-10
Medical Product Outsourcing
FDA Clears VUNO's Med-DeepBrain AI Software
VUNO's Med-DeepBrain AI-powered brain quantification device received FDA 510(k) clearance in October 2023. This software automates the analysis of MRI images to provide volumetric data on over 100 brain regions, cortical thickness, and white matter hyperintensity, assisting in the diagnosis of dementia and other neurodegenerative diseases.
2023-10
EIN Presswire
VUNO'S CORE TECHNOLOGY FOR EARLY DIAGNOSIS OF ALZHEIMER'S RECEIVED U.S. PATENT
VUNO announced in June 2024 that a U.S. patent was registered for the core technology of VUNO Med®-DeepBrain®, specifically for analyzing the thickness of cortical regions of the brain. This patented technology quickly and accurately analyzes cortical thickness, a biomarker for early Alzheimer's diagnosis, and will be showcased at the 2024 Alzheimer's Association International Conference.
2024-06
AuntMinnie
FDA clears Vuno's DeepBrain brain quantification software
The U.S. Food and Drug Administration (FDA) cleared South Korean AI developer Vuno's brain quantification software, Vuno Med-DeepBrain, in October 2023.
2023-10
KED Global
Vuno's brain imaging AI medical device secures FDA certification
Vuno announced in October 2023 that its AI-powered brain quantification device, Vuno Med-DeepBrain, received 510(k) certification from the US FDA. This technology analyzes brain MRI scans to segment the brain into over 100 distinct areas, rapidly quantifying atrophy and assisting in diagnosing dementia and neurodegenerative conditions.
2023-10
VUNO (via Nature.com)
Deep learning-based diagnosis of Alzheimer's disease using brain magnetic resonance images: An empirical study
A study published in October 2022 investigated VUNO Med-DeepBrain AD (DBAD) as a decision support service for Alzheimer's disease diagnosis. The study found that DBAD's accuracy, sensitivity, and specificity for diagnosing AD were comparable to medical experts, with DBAD showing a higher trend in every analysis.
2022-10

Videos

Product demos, reviews, and walkthroughs for VUNO Med-DeepBrain.

View all on YouTube

Frequently Asked Questions

VUNO Med-DeepBrain is an AI-powered medical device that analyzes brain MRI scans to provide quantitative measurements of brain atrophy. It aids neurologists in the early detection and management of major degenerative brain diseases by offering objective data on brain volume changes.
Yes, VUNO Med-DeepBrain has received regulatory clearances, including FDA 510(k) and CE marking, indicating its compliance with medical device safety and performance standards. It also adheres to data privacy regulations to ensure patient information is protected.
VUNO Med-DeepBrain offers a fully automated and quantitative analysis of brain MRI, which can be more efficient and objective than traditional visual assessments. While other AI solutions exist, VUNO Med-DeepBrain differentiates itself through its specific algorithms and validation for various degenerative brain diseases.
Potential limitations include the need for high-quality MRI scans for optimal analysis and ensuring seamless integration with existing PACS and EMR systems. Physicians may also need training to fully understand and interpret the AI-generated reports within their clinical context.
The pricing model for VUNO Med-DeepBrain can vary, often based on licensing agreements or per-use fees. Regarding insurance coverage, it depends on the specific healthcare system and reimbursement policies in place for AI-powered diagnostic tools.
VUNO Med-DeepBrain's accuracy and clinical utility are supported by various studies and its regulatory clearances. These validations demonstrate its effectiveness in providing reliable quantitative data for brain atrophy assessment, aiding in the diagnosis and monitoring of neurodegenerative diseases.
VUNO Med-DeepBrain provides quantitative measurements of brain atrophy in various regions, which can be indicative of different neurodegenerative diseases. While it aids in identifying patterns consistent with specific conditions, a definitive diagnosis always requires comprehensive clinical evaluation by a neurologist.

Related Tools

Parkiwatch
Koios Care
Neurology AI
Parkiwatch by Koios Care is a Class IIa Software as a Medical Device (EU MDR 2017/745) for continuous, passive detection and quantitative assessment of kinematic patterns representative of tremor, bradykinesia, and dyskinesia in adults with Parkinson's Disease.
Paid
CortiCare (Virtual EEG Department)
CortiCare
Neurology AI
CortiCare offers 24/7 remote EEG monitoring and interpretation services, functioning as a virtual EEG department to assist hospitals and neurology practices in identifying seizures and other neurological conditions.
NeuroAstra
Avinya NeuroTech
Clinical Decision Support & Reference
NeuroAstra is an AI-enabled EEG analysis and reporting software that provides a multimodal clinical EEG web platform with Co-Pilot AI to help neuro care teams detect abnormal trends faster and standardize reporting.
Cercare Medical Oncology Virtual Expert
Cercare Medical
Neurology AI
Cercare Medical's Oncology Virtual Expert is an AI-powered brain tumor segmentation module that provides fast, consistent, and semi-automated tumor analysis from standard MRI data, designed for on-premise deployment within existing clinical radiology workflows.
CoLumbo C-Spine
Smart Soft Healthcare AD
Clinical Decision Support & Reference
CoLumbo C-Spine is an AI-powered software that processes and analyzes cervical spine MRI exams, assisting clinicians in diagnosis and assessment.
MeRT System
Wave Neuroscience
Mental & Behavioral Health AI
MeRT (Magnetic e-Resonance Therapy) is an advanced, personalized form of TMS that uses your own brainwave data to guide treatment. It's a non-invasive, drug-free option designed to help the brain communicate more efficiently so symptoms of conditions like depression, anxiety, PTSD, TBI, autism, and more can improve.
Paid

See all Neurology AI tools →

More from VUNO

VUNO Med-Chest X-ray Triage/VUNO Med-CXR Link Triage
VUNO Inc.
Radiology & Imaging AI
VUNO Med-Chest X-ray Triage/VUNO Med-CXR Link Triage is an FDA-cleared AI-based software that analyzes adult chest X-rays to rapidly detect pleural effusion and pneumothorax, prioritizing urgent cases in clinical workflows.

View company profile →

Suggest an Edit → | Report an issue | Last Verified: 2026-04-19 | First Added: 2026-04-19
AI Tool Finder
AI-powered search. Results may not be comprehensive.